The prevalence of apathy in Lewy body dementia: A systematic review and meta-analysis
Jenny Jia Yu1,2, Kai Sin Chin1,2, Paula M Loveland1,2
1Melbourne Brain Centre @ The Royal Melbourne Hospital, Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
Introduction:
Apathy is an important syndrome in Lewy body dementia (LBD), although reported prevalences vary. We aimed to estimate the prevalence of apathy in LBD through systematic review and meta-analysis.
Methods:
Five databases were searched for articles reporting the prevalence of apathy in LBD (dementia with Lewy bodies [DLB] and Parkinson's disease dementia [PDD]) and prodromal/mild cognitive impairment (MCI) LBD. Linear mixed model random effect meta-analysis was performed to determine the prevalence of apathy.
Results:
Of 7846 articles identified, 49 met inclusion criteria. The average pooled prevalence of apathy was 57% (95% confidence interval [CI] 52%-63%, I2 = 85.6%) in DLB, 56% (95% CI 43%-70%, I2 = 97.6%) in PDD, 46% (95% CI 32%-61%, I2 = 90.6%) in Lewy body-MCI, and 38% (95% CI 25%-50%, I2 = 88.1%) in Parkinson's disease-MCI.
Discussion:
Apathy affects more than half of individuals with LBD. The high prevalence in prodromal DLB supports the notion that apathy may assist in more timely and accurate diagnosis of DLB.
Highlights:
Reported apathy prevalence in Lewy body dementia (LBD) varies widely in the existing literature. The pooled prevalence of apathy was > 50% in LBD and > 40% in prodromal disease stages. Apathy may have utility in earlier, more accurate diagnosis of dementia with Lewy bodies.
More Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Alzheimer's Disease: Treatment
